8 news items
Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease
CGTX
21 May 24
statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this press release, other than
Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update
CGTX
7 May 24
Litigation Reform Act of 1995. All statements contained in this press release, other than statements of historical facts or statements that relate
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's Disease
CGTX
22 Apr 24
Securities Litigation Reform Act of 1995. All statements contained in this press release, other than statements of historical facts or statements
Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference
CGTX
2 Apr 24
Securities Litigation Reform Act of 1995. All statements contained in this press release, other than statements of historical facts or statements that relate
Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
CGTX
26 Mar 24
contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this press
ez0zs1usfu46w92shvf8adyqmqcfrf4o
CGTX
15 Mar 24
-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this press release, other than
92odi3j50
CGTX
11 Mar 24
-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this press release, other
ha60ro7yvha67zn2cib83xnbys4mgncejrumn6drpo36308fsobvuclory3z
CGTX
6 Mar 24
the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this press release, other than statements of historical
- Prev
- 1
- Next